PCR inhibition is frequent in medical microbiology routine practice and may lead to 22 false-negative results; however there is no consensus on how to detect it. Pathogen-specific 23 and human gene amplifications are widely used to detect PCR inhibition. We aimed at 24 comparing the value of PCR inhibitor detection using these two methods. We analysed Cp 25 shifts (Cp) obtained from qPCRs targeting either the albumin gene or the pathogen-specific 26 sequence used in two laboratory-developed microbiological qPCR assays. 3152 samples 27 including various matrixes were included. Pathogen-specific amplification and albumin qPCR 28 identified 62/3152 samples (2.0 %), and 409/3152 (13.0%) samples, respectively, as inhibited.
Introduction 36
Molecular biology and particularly real-time PCR (qPCR) has revolutionized the biological 37 diagnosis of infectious diseases. Nonetheless, PCR may fail because it is based on an 38 enzymatic reaction susceptible to various mechanisms of inhibition [1] . Inhibition of PCR 39 reaction is frequent in clinical microbiology and exposes to the risk of false negative results, 40 hence PCR inhibition screening is recommended [2, 3] . PCR inhibition appears as a hardly 41 predictable event and data about its actual frequency in routine practice of clinical biology 42 laboratories are scarce [4, 5] . Differential susceptibility of each type of qPCR to different 43 inhibitors and heterogeneity of sample matrixes make its detection non trivial. Many methods 44 to detect PCR inhibition have been reported and some guidelines have been published. The 45 use of PCR controls with a defined quantity of DNA molecules to check for the presence of a 46 Cp switch due to the presence of inhibitors in the sample extract is relevant; however it is 47 risky since technicians may have to manipulate and distribute target DNA, thus increasing the 48 risk of inter-well contamination. 'Internal' amplification controls, based on alien DNA added 49 at a low concentration in the specimen before DNA extraction, and of which the presence 50 must be checked in a duplex PCR together with the target, is also highly relevant. Most of 51 commercial inhibition controls are based on this principle. The rationale of using a human 52 gene as an extraction or inhibition control is less acceptable because the human DNA target is 53 present in high quantity in the sample as compared to the target DNA [6] . Importantly, there 54 is presently no consensus for PCR inhibition detection in routine practices. The Toxoplasma qPCR targeted the 'rep529' sequence (AF146527) and was performed as 101 described by Reischl et al. [14] . The Pneumocystis qPCR targeted the major surface 102 glycoprotein gene (AF372980) and was performed as described by Fillaux et al. [15] . We 
Performances of PCR inhibition detection using albumin-qPCR
202 409/3152 samples (12.9%) exhibited a Cp alb above the threshold, i.e. above the mean Cp for 203 the matrix concerned + 3 (Table 1) . Thus, (i) the albumin-qPCR identified many more 204 samples as containing inhibitors than the pathogen-specificcontrols, and this was so in both 205 qPCR assays, i.e. 285 vs. 45 for the Toxoplasma assay, and 127 vs. 17 for the Pneumocystis 206 assay. In addition, (ii) it is noteworthy that only 13 and 3 samples were detected as inhibited 207 using both inhibitor-detection methods, for the Toxoplasma and Pneumocystis assays, 208 respectively ( Figure 2) . We therefore conclude that (i) the human gene-based qPCR detected 209 inhibitors much more often than the pathogen-specificqPCR and (ii) it most often did not 210 detect them correctly. Considering this poor correlation between pathogen-specific controls 211 and albumin qPCR to detect PCR inhibitors, we wished to determine Cp alb thresholds more 212 adapted to our assays. To do so, we calculated the sensitivity, specificity of the albumin qPCR 213 to detect PCR-inhibiting samples using the pathogen-specific control as reference and the 214 Youden's index (Sensitivity + Specificity -1) and we varied the Cp alb threshold (see Methods
215
and Figure 3A ). We could not determine a Cp alb threshold allowing to obtain 95 % sensitivity 216 and 95 % specificity ( Figure 3B ), whether this strategy was used for all matrixes together or 217 for each type of matrix ( Figure S3 and Figure S4 ). We therefore concluded that no Cp alb cut-218 off values can be determined to efficiently detect pathogen-specific inhibitions for both 219 pathogen-specific PCR assays. To check the influence of the cellularity of clinical samples on 220 Cp alb values, we compared white blood cell counts to albumin qPCR results for blood 221 samples. We analysed 1690/1874 blood samples; the remaining 184 samples were excluded 222 from the analysis due to the absence of whole blood cell count on the same day as 223 Toxoplasma-PCR. Cp alb values were correlated to leucocyte counts (p<0.0001; Spearman's 224 rank correlation), but for a given white blood cell count a large range of Cp alb was observed 225 (Figure 4) . The lack of sensitivity and specificity of albumin PCR to detect target specific 226 inhibitions may be explained by a differential susceptibility of each qPCR assay to inhibitors 227 and by the variable quantity of human DNA in clinical samples. These results prevent using 228 human gene-based PCR, e.g. albumin, betaglobin or human RNase P genes, as PCR inhibition 229 detection method.
230
Another widely used method to search for inhibitors is the use of commercial "universal" 231 controls. These commercial controls are made of exogenous DNA and are added either in the 232 sample before extraction or with the DNA extract in the PCR mix. Differential susceptibility 233 to inhibitors and efficiency discrepancies between PCR assays should also prove problematic 234 in this approach. Indeed, the size and GC rate of the amplicons of the foreign DNA used will 235 have an impact on the detection of the inhibition [9] . So, implementation of one of these 236 controls should be avoided until their performances have been assessed in routine practice.
237
In conclusion, pathogen-specific amplification controls appear to be a method of 238 choice for screening the presence of inhibitors in a PCR assay for infectious diseases as 239 compared to the use of a human gene-based qPCR . 
